Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.20 0.34% 1,555.20 1,553.20 1,554.20 1,564.40 1,546.20 1,557.00 5,612,579 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 16.6 78,025

GlaxoSmithKline PLC Director/PDMR Shareholding

10/07/2020 4:41pm

UK Regulatory (RNS & others)


TIDMGSK

RNS Number : 7231S

GlaxoSmithKline PLC

10 July 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP16.1054                                                             11 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications & CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP16.1054                                                             4 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                   Mr D Jackson 
====  ======================================  ===================================================== 
 b)    Position/status                        PCA of Ms S Jackson (SVP, Global Communications 
                                               & CEO Office) 
====  ======================================  ===================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ===================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ===================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ===================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ===================== 
   GBP16.1054                                                               1 
   =======================================================================  ===================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================ 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ===================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms V Whyte 
====  ======================================  ================================================= 
 b)    Position/status                        Company Secretary 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP16.1054                                                             29 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr I Whyte 
====  ======================================  ================================================= 
 b)    Position/status                        PCA of Ms V A Whyte (Company Secretary) 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP16.1054                                                             883 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Connor 
====  ======================================  ================================================= 
 b)    Position/status                        PCA of Mr R G Connor (President, Global 
                                               Vaccines) 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 July 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP16.1054                                                             455 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-07-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEBLFFBDLZBBB

(END) Dow Jones Newswires

July 10, 2020 11:41 ET (15:41 GMT)

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200809 08:20:57